We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
1276
CALL
Kimberly-Clark
KMB
$36.9B
$15M 0.01%
124,300
+7,500
+6% +$875K
STOR
1277
DELISTED
STORE Capital Corporation
STOR
$15M 0.01%
574,577
+560,643
+4,024% +$14.3M
DLR icon
1278
PUT
Digital Realty Trust
DLR
$74.3B
$15M 0.01%
131,300
+94,100
+253% +$11.1M
DXJ icon
1279
PUT
WisdomTree Japan Hedged Equity Fund
DXJ
$7.53B
$14.9M 0.01%
251,700
+17,600
+8% +$1.02M
CTB
1280
DELISTED
Cooper Tire & Rubber Co.
CTB
$14.9M 0.01%
422,342
-46,106
-10% -$1.63M
IPGP icon
1281
PUT
IPG Photonics
IPGP
$3.61B
$14.9M 0.01%
69,500
+50,000
+256% +$10.6M
ECHO
1282
EchoStar
ECHO
$26.5B
$14.9M 0.01%
306,065
-157,151
-34% -$7.3M
GSK icon
1283
GSK
GSK
$98.3B
$14.9M 0.01%
335,038
-15,888
-5% -$734K
DRI icon
1284
PUT
Darden Restaurants
DRI
$25.4B
$14.8M 0.01%
154,500
+16,100
+12% +$1.36M
BLUE
1285
DELISTED
bluebird bio
BLUE
$14.8M 0.01%
6,426
+6,001
+1,412% +$12.2M
ROK icon
1286
PUT
Rockwell Automation
ROK
$49.9B
$14.8M 0.01%
75,500
+15,400
+26% +$2.94M
RDC
1287
DELISTED
Rowan Companies Plc
RDC
$14.8M 0.01%
946,199
-73,476
-7% -$1.03M
CNI icon
1288
PUT
Canadian National Railway
CNI
$77.3B
$14.8M 0.01%
179,600
-17,800
-9% -$1.43M
AA icon
1289
CALL
Alcoa
AA
$13.3B
$14.8M 0.01%
275,000
-38,600
-12% -$1.77M
AA icon
1290
PUT
Alcoa
AA
$13.3B
$14.8M 0.01%
274,800
+70,800
+35% +$3.24M
GLNG icon
1291
PUT
Golar LNG
GLNG
$5.27B
$14.8M 0.01%
495,100
+163,400
+49% +$3.93M
MOS icon
1292
CALL
The Mosaic Company
MOS
$6.96B
$14.7M 0.01%
572,000
+90,200
+19% +$2.07M
SPLK
1293
CALL
DELISTED
Splunk Inc
SPLK
$14.6M 0.01%
176,800
+62,700
+55% +$4.6M
ACH
1294
Accendra Health
ACH
$81.5M
$14.6M 0.01%
772,267
+700,585
+977% +$15.5M
SBAC icon
1295
SBA Communications
SBAC
$19.8B
$14.5M 0.01%
+89,025
New +$14.1M
XME icon
1296
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.58B
$14.5M 0.01%
399,800
+88,200
+28% +$2.88M
XLP icon
1297
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$14.5M 0.01%
254,500
+131,600
+107% +$7.23M
PH icon
1298
PUT
Parker-Hannifin
PH
$134B
$14.5M 0.01%
72,500
+5,500
+8% +$1.02M
EVH icon
1299
Evolent Health
EVH
$518M
$14.5M 0.01%
1,175,780
+480,036
+69% +$6.77M
DHR icon
1300
CALL
Danaher
DHR
$143B
$14.4M 0.01%
175,404
-902
-0.5% -$73.3K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.